Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Finding Study for Reversal of Vecuronium-induced Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine

NCT03656614 is registered in ClinicalTrials.gov with Guangzhou General Hospital of Guangzhou Military Command as lead sponsor.

NCT NCT03656614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03656614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Finding Study for Reversal of Vecuronium-induced Neuromuscular Blockade at Train-of-four Ratio 0.3 With Sugammadex and Neostigmine
Lead sponsor
Guangzhou General Hospital of Guangzhou Military Command
Phase
Observational
Overall status
Completed
Start date
July 26, 2018
Completion date
June 30, 2019
Enrollment
121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuromuscular blockade